Koninklijke Dsm Nv Stock Current Valuation
| KDSKFDelisted Stock | USD 25.30 0.00 0.00% |
Valuation analysis of Koninklijke DSM NV helps investors to measure Koninklijke DSM's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Koninklijke DSM's price fluctuation is very steady at this time. Calculation of the real value of Koninklijke DSM NV is based on 3 months time horizon. Increasing Koninklijke DSM's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Koninklijke pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Koninklijke DSM NV. Since Koninklijke DSM is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Koninklijke Pink Sheet. However, Koninklijke DSM's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 25.3 | Real 24.04 | Hype 25.3 | Naive 27.36 |
The real value of Koninklijke Pink Sheet, also known as its intrinsic value, is the underlying worth of Koninklijke DSM NV Company, which is reflected in its stock price. It is based on Koninklijke DSM's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Koninklijke DSM's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Koninklijke DSM NV helps investors to forecast how Koninklijke pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Koninklijke DSM more accurately as focusing exclusively on Koninklijke DSM's fundamentals will not take into account other important factors: Koninklijke DSM NV Company Current Valuation Analysis
Koninklijke DSM's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Koninklijke DSM Current Valuation | 23.38 B |
Most of Koninklijke DSM's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Koninklijke DSM NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Koninklijke DSM NV has a Current Valuation of 23.38 B. This is 104.88% higher than that of the Basic Materials sector and 24.13% lower than that of the Specialty Chemicals industry. The current valuation for all United States stocks is 40.61% lower than that of the firm.
Koninklijke Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Koninklijke DSM's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Koninklijke DSM could also be used in its relative valuation, which is a method of valuing Koninklijke DSM by comparing valuation metrics of similar companies.Koninklijke DSM is currently under evaluation in current valuation category among its peers.
Koninklijke Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0402 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 23.38 B | |||
| Shares Outstanding | 172.97 M | |||
| Shares Owned By Insiders | 0.09 % | |||
| Shares Owned By Institutions | 56.99 % | |||
| Price To Earning | 37.75 X | |||
| Price To Book | 2.12 X | |||
| Price To Sales | 2.27 X | |||
| Revenue | 9.2 B | |||
| Gross Profit | 3.16 B | |||
| EBITDA | 1.71 B | |||
| Net Income | 1.68 B | |||
| Cash And Equivalents | 1.63 B | |||
| Cash Per Share | 9.44 X | |||
| Total Debt | 2.84 B | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 2.51 X | |||
| Book Value Per Share | 56.38 X | |||
| Cash Flow From Operations | 1.43 B | |||
| Earnings Per Share | 6.71 X | |||
| Price To Earnings To Growth | 2.88 X | |||
| Number Of Employees | 21.76 K | |||
| Beta | 0.71 | |||
| Market Capitalization | 22.49 B | |||
| Total Asset | 16.01 B | |||
| Working Capital | 2.7 B | |||
| Current Asset | 4.9 B | |||
| Current Liabilities | 2.2 B | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 16.01 B | |||
| Last Dividend Paid | 2.63 |
About Koninklijke DSM Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Koninklijke DSM NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Koninklijke DSM using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Koninklijke DSM NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Koninklijke Pink Sheet
If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |